Christopher Polk, MD

Associate Professor
Atrium Health
Charlotte, North Carolina, United States

Christopher Polk, MD is an Associate Professor of Medicine and Assistant Specialty Director of Infectious Diseases for Research in the Division of Infectious Diseases at Atrium Health in Charlotte, NC. Research interests include COVID-19, CRE-producing infections, and HIV. A primary focus and funding is industry-sponsored clinical trials of new antimicrobials, but also lead investigator initiated research examining new treatment paradigms for CRE infections and HIV. With COVID-19, he has helped develop and lead protocols for Atrium Health’s treatment approach for patients. This includes leading Atrium's clinical trial effort in development of innovative new therapeutic options to improve patient outcomes.

Disclosure(s): No financial relationships to disclose

Presentation(s):

• 311 - Defining the magnitude of desirability of outcome ranking (DOOR) differences in effectiveness of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)

  Friday, October 18, 2024
  10:42 AM – 10:54 AM US PT

• 312 - Impact of Patient Subgroups on the Efficacy of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for Multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)

  Friday, October 18, 2024
  10:54 AM – 11:06 AM US PT